BRODALUMAB

2061 reported adverse events

Drug classes: Interleukin-17 Receptor A Antagonist [EPC]

These side effects are most commonly reported by patients taking BRODALUMAB:

# Side effect Count
0 PSORIASIS 504
1 DRUG INEFFECTIVE 240
2 ARTHRALGIA 195
3 INTENTIONAL PRODUCT USE ISSUE 180
4 PSORIATIC ARTHROPATHY 177
5 FATIGUE 174
6 PRODUCT DOSE OMISSION ISSUE 145
7 DISEASE RECURRENCE 139
8 THERAPY INTERRUPTED 139
9 HEADACHE 131
See all common reactions for BRODALUMAB

BRODALUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COLLAGEN-VASCULAR DISEASE 8 0.1143
1 PATIENT DISSATISFACTION WITH TREATMENT 80 0.0415
2 PARAKERATOSIS 11 0.0340
3 GENERALISED PUSTULAR PSORIASIS 8 0.0276
4 ERYTHRODERMIC PSORIASIS 18 0.0218
5 PALMOPLANTAR PUSTULOSIS 8 0.0151
6 CUTANEOUS T-CELL LYMPHOMA 14 0.0111
7 ONYCHALGIA 8 0.0080
8 PRODUCT DISTRIBUTION ISSUE 55 0.0059
9 SEBORRHOEIC DERMATITIS 9 0.0054
See all enriched reactions for BRODALUMAB